MICROVISION, INC. (MVIS)

Markham Drew G 🟡 adjusted position in 340.9K shares (3 derivative) of MICROVISION, INC. (MVIS) at $0.36 Transaction Date: Jun 08, 2026 | Filing ID: 028198

Register to leave comments

  • News bot June 11, 2026, 1:57 a.m.

    🔍 Markham Drew G (Executive)

    Company: MICROVISION, INC. (MVIS)

    Report Date: 2026-06-08

    Transaction Summary:

    • Total transactions: 6
    • Derivative instruments: 3
    • Holdings reported: 0
    • Total shares acquired: 418,800
    • Total shares sold: 77,905

    Detailed Transactions and Holdings:

    • Acquired 150,000 shares of Common Stock (Direct)
      Date: 2026-06-08 | Code: M | equity_swap_involved: 0 | shares_owned_after: 622,308.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 118,800 shares of Common Stock (Direct)
      Date: 2026-06-08 | Code: M | equity_swap_involved: 0 | shares_owned_after: 741,108.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 77,905 shares of Common Stock at $0.3621 per share (Direct)
      Date: 2026-06-10 | Code: F | equity_swap_involved: 0 | shares_owned_after: 663,203.00 | transaction_form_type: 4 | Footnotes: F2, F3
    • Acquired 150,000 shares of Restricted Stock Units (Derivative)
      Date: 2026-06-08 | Code: A | Expires: 2026-06-08 | Exercise: 2026-06-08 | equity_swap_involved: 0 | shares_owned_after: 150,000.00 | transaction_form_type: 4 | Footnotes: F4, F5
    • Sold 0 shares of Restricted Stock Units (Derivative)
      Date: 2026-06-08 | Code: M | Expires: 2026-06-08 | Exercise: 2026-06-08 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F6, F5
    • Sold 0 shares of Restricted Stock Units (Derivative)
      Date: 2026-06-08 | Code: M | Expires: 2026-06-08 | Exercise: 2026-06-08 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F6, F7

    Footnotes:

    • F1: Vested restricted stock units, or RSUs, were distributed to the Reporting Person, without payment, in shares of common stock on a unit-for-share basis.
    • F2: Represents a withholding tax-related nondiscretionary sell-to-cover transaction completed by the Issuer in accordance with the terms of the award agreement.
    • F3: The price reported in column 4 is a weighted average price. These shares were sold by the Issuer in multiple transactions at prices ranging from $0.3509 to $0.3779, inclusive.
    • F4: Each RSU represents a contingent right to receive one share of MicroVision common stock.
    • F5: RSUs vested on June 8, 2026, on the one-year anniversary of grant, upon determination by the Issuer's Compensation Committee of the level of achievement of performance objectives pursuant to the 2025 Executive Bonus Plan.
    • F6: At vesting, converts into shares of common stock on a unit-for-share basis.
    • F7: On June 6, 2025, the Issuer's Compensation Committee approved a grant of RSUs, which are scheduled to vest as to 33% on each annual anniversary of the grant date until fully vested on June 6, 2028, subject to the Reporting Person's continued employment with the Issuer on each vesting date.